Approval for new drugs

DUBAI - Pfizer Inc. has announced that it has received approval from the UAE Ministry of Health to register and market two new medical products: Bextra film coated tablets, the newest COX-2 selective inhibitor in its portfolio, for the treatment of patients with pain and inflammation associated with osteoarthritis and rheumatoid arthritis; and the fist injectable Cox-2 inhibitor, Dynastat, for treatment of post-operative pain.

By A Staff Reporter

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Tue 30 Sep 2003, 12:57 PM

Last updated: Wed 1 Apr 2015, 11:52 PM


More news from